Combining Remdesivir And Hepatitis C Drugs May Give Covid 19 Treatment A Boost
Researchers at Rensselaer Polytechnic Institute (RPI), the University of Texas at Austin, and the Icahn School of Medicine at Mount Sinai found that four drugs used against hepatitis C—simeprevir, vaniprevir, paritaprevir, and grazoprevir—boosted the effectiveness of remdesivir tenfold. The April study was published in the journal Cell Reports. One caveat: Researchers have only studied this combination treatment in cells, not humans. Although the drugs being studied for use with remdesivir have been approved by the Food and Drug Administration (FDA) for treating people with hepatitis C, it is not known if the combination will be effective against COVID-19 in humans....